Curis (CRIS) Capital Expenditures (QoQ) (2010 - 2022)
Curis (CRIS) Capital Expenditures (QoQ) (2010 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Curis |
8.37 Mn |
-6.63 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2022 |
-85.27% |
| Jun 30, 2022 |
3,109.09% |
| Dec 31, 2020 |
-87.34% |
| Sep 30, 2020 |
-66.60% |
| Jun 30, 2020 |
1,719.23% |
| Sep 30, 2018 |
211.59% |
| Jun 30, 2018 |
-189.61% |
| Mar 31, 2018 |
87.80% |
| Dec 31, 2017 |
95.24% |
| Sep 30, 2017 |
-71.62% |
| Jun 30, 2017 |
42.31% |
| Mar 31, 2017 |
-13.33% |
| Dec 31, 2016 |
361.54% |
| Sep 30, 2016 |
-94.76% |
| Jun 30, 2016 |
3,000.00% |
| Sep 30, 2015 |
76,644.19% |
| Jun 30, 2015 |
-99.71% |
| Mar 31, 2015 |
-42.99% |
| Dec 31, 2014 |
280.07% |
| Dec 31, 2013 |
-81.35% |
